Authors


Johlee S. Odinet, PharmD, BCPS, CPPS

Latest:

Fellowship Focus: Elevating Pediatric Medication Safety Through Data, AI, and Collaboration

Ochsner Children’s Hospital, in partnership with ISMP, has launched a fellowship to advance pediatric medication safety through hands-on training in key competencies, national safety strategies, interdisciplinary collaboration, and innovative tools such as AI and data dashboards.


Cassidy Hixon, PharmD Candidate 2025

Latest:

Updated Clinical Guidelines Outline Optimal Treatment of Helicobacter pylori Infection

For pharmacists wondering whether bismuth quadruple therapy still reigns as the gold standard, the wait is over—the latest recommendations are here.


Brandon Newman, PharmD, MMHC, CSP

Latest:

How Data Can Help Demonstrate the Value of the Health-System Specialty Pharmacy

Insurers, accountable care organizations, and manufacturers increasingly look for demonstrable clinical outcomes as proof for reimbursement or access to limited distribution networks.


Gretchen Brummel, PharmD, BCPS

Latest:

As Shortages Continue, Suppliers, Hospitals, and Health Systems Look for New Solutions

Hospitals, health systems, and the supply chain are all negatively impacted by drug shortages and are each affected by the decisions of the others.


Sarah Thomas

Latest:

Asembia AXS25: Digital Pharmacy Strategies for Patient-Centered Care

Digital pharmacy solutions are revolutionizing patient care.


Danielle Wilson, PharmD, Candidate 2023

Latest:

Commonly Overlooked Adverse Effects in the Community, Clinical Pharmacy Settings

Although pharmacists possess a wealth of knowledge on AEs, it remains a monumental task to recall the clinical significance of every AE, even with the most commonly used medications.


Jessica Geiger, PharmD, MS, BCPS

Latest:

Integration of Palliative Pharmacists to Elevate Oncologic Care

Palliative pharmacists are invaluable assets of oncologic care.


Sharon Faust, PharmD

Latest:

Managing Sustainable Drug Spend: 5 Trends Reshaping Pharmacy Benefits in 2025

The US health care market faces transformative changes in 2025, as biosimilars, GLP-1s, and new pharmacy economics reshape how benefit managers balance innovation with affordability.


Sasha Watson, PharmD, BCOP

Latest:

Precision Oncology in Focus: ctDNA's Role in Colon Cancer Management

Sasha Watson, PharmD, BCOP, discusses the emerging role of circulating tumor DNA (ctDNA) in colon cancer, highlighting its potential to enhance precision oncology by improving early detection, guiding adjuvant therapy decisions, and monitoring disease recurrence and treatment resistance.



Daniel Streetman, PharmD, MS

Latest:

Interaction Considerations for Common OTC Drug Classes

Although OTC medications are generally considered safe when used as directed, there are some key drug interactions for pharmacists to keep in mind when helping patients choose an OTC product.


Meera Mehta, PharmD, BCIDP

Latest:

Pharmacists Have a Significant Role in the Prevention of Travel-Related Diseases

When helping individuals prepare for travel, pharmacists must make travel health recommendations and know common travel-related immunizations and additional resources.


Jennifer N. Tovar, PharmD Candidate

Latest:

AHA Statement Reviews Benefits, Risks of Alternative Therapies for Heart Failure

The AHA acknowledged that complementary and alternative medicines are widely used by heart failure patients but warned that there is limited scientific evidence to support their efficacy.


Yanguang Cao, PhD

Latest:

Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD

This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.


Dean Earhardt

Latest:

Balancing Pharmaceutical Reimbursement and Market Access With the Right Partner

Manufacturers must find the right balance in drug pricing, so that medications are appealing to both public and private insurers while still remaining profitable throughout their lifecycle.


Drew Gazetos, PharmD

Latest:

Case Study: New Treatment Options for Patients With Chronic Lymphocytic Leukemia

With a better understanding of the underlying pathophysiology of chronic lymphocytic leukemia and the introduction of novel targeted agents, such as Bruton kinase Inhibitors, the prognosis of high-risk patients has changed dramatically.


Nicole C. Pezzino, PharmD, BCACP, CDCES

Latest:

Vax-Innovation: Incorporating the Newly Approved RSV and Pneumococcal Vaccines Into Community Pharmacy Workflow

Best practices to train staff and team members to engage patients and to ease the new vaccine offerings into the workflow are also discussed.


Rose Ftiha, PharmD Candidate

Latest:

St. John’s Wort Could Show Benefit in Major Depressive Disorder

Patients with MDD may also seek complementary or alternative therapies in the form of dietary supplements which might be perceived by patients to be natural and safer than medicinal agents.


Beeham Lee, DVM, MBA

Latest:

Comparative Oncology: Advances in Cancer Care from Pets to Humans

Dogs share a number of cancers with humans, including melanoma, non-Hodgkin lymphoma, leukemia, and osteosarcoma.


Matthew Zirwas, MD

Latest:

Understand Effective Strategies for Monitoring Topical Dermatological Agents

Matthew Zirwas, MD, highlights the discrepancy between perceived and actual usage, citing studies that reveal patients often overestimate their compliance.


Erin Satterwhite

Latest:

Pharmacy’s Role in Treating Rare Disease: Connecting Patients, Providers, Payers, and Pharma

Pharmacy's position at the intersection of the care team gives it a unique ability to connect providers, payers, and pharmaceutical manufacturers, and support patients to maximize their health outcomes.


Yulianna Laurencin, PharmD Candidate

Latest:

The Blood Detective: Tackling Medication-Induced Hematological Disorders

These disorders can be fatal, making pharmacists’ role in detection crucial.


Rose DiMarco, PharmD, BCPS, BCOP

Latest:

Advances in the Management of HR+/HER2– Ultralow and -Low Metastatic Breast Cancer: New Horizons and Treatment Frontiers

Antibody-drug conjugates have revolutionized metastatic breast cancer treatment and classification.


Ketaki Apti

Latest:

Metal Ion Chelators Hold Enormous Potential in Neurodegenerative Disorders

Monitoring metal ion concentrations and chelation therapy is hypothesized to alleviate symptoms and diseases caused by neuroinflammation.


Gustavo Alva, MD

Latest:

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD, a board-certified psychiatrist, discusses the importance of mental health awareness among pharmacists and patients.


Kevin Cleveland, PharmD

Latest:

Pharmacy Students Lead Drive-Through Influenza Vaccination Event

Idaho State University partners with the Idaho Immunization Coalition to effectively and safely vaccinate patients against influenza.




Hunter Sowell, PharmD

Latest:

Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing Sarcoma

This retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.


Cortney Steward. PharmD Candidate

Latest:

Research Underscores the Critical Role of Pharmacists in Managing Stiff Person Syndrome

Stiff Person Syndrome has unique complexities, necessitating the role of pharmacists in managing its symptoms and treatment options.